1.13
price down icon1.74%   -0.02
after-market 시간 외 거래: 1.13
loading

Artelo Biosciences Inc 주식(ARTL)의 최신 뉴스

pulisher
Nov 20, 2024

Artelo Biosciences (ARTL) Stock Surges Amid Strong Buy Ratings - GuruFocus.com

Nov 20, 2024
pulisher
Nov 18, 2024

Artelo Biosciences to Present Key Drug Development Data at Major Cannabinoid Summit | ARTL Stock News - StockTitan

Nov 18, 2024
pulisher
Nov 18, 2024

HC Wainwright Has Negative Outlook of ARTL FY2024 Earnings - Defense World

Nov 18, 2024
pulisher
Nov 15, 2024

HC Wainwright Reiterates “Buy” Rating for Artelo Biosciences (NASDAQ:ARTL) - Defense World

Nov 15, 2024
pulisher
Nov 14, 2024

Cancer Anorexia Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Helsinn Healthcare, Artelo Biosciences, NGM Biopharmaceuticals - The Globe and Mail

Nov 14, 2024
pulisher
Nov 13, 2024

Artelo Biosciences Reports Q3 2024 Financials and Progress - TipRanks

Nov 13, 2024
pulisher
Nov 13, 2024

Artelo Biosciences (ARTL) Stock Dips Amidst Financial Report - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

Artelo Biosciences Announces Promising New Data on Novel Non-Opioid Treatment Approach for Osteoarthritis Pain at the 13th Annual Musculoskeletal Repair and Regeneration Symposium - The Manila Times

Nov 13, 2024
pulisher
Nov 13, 2024

Artelo's Pain Drug Outperforms Naproxen in Key Study; FDA Clears Phase 1 Trial | ARTL Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 12, 2024

Tempest Receives FDA Study May Proceed for Pivotal Phase 3 Trial of Amezalpat Combination Therapy for the Treatment of First-Line Hepatocellular Carcinoma - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

Artelo Bio Slashes Losses 54%, Advances Pipeline with Multiple Clinical Trials Ahead | ARTL Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 07, 2024

Artelo Biosciences (ARTL) Shares Dive Amidst Biotech Sector Move - GuruFocus.com

Nov 07, 2024
pulisher
Nov 05, 2024

Vaccinex Reports Improved Immunity Correlating with Clinical Benefit of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer's Annual Meeting - The Manila Times

Nov 05, 2024
pulisher
Nov 05, 2024

Artelo Biosciences Announces Acceptance of ART26.12 into the National Institutes of Health’s “Preclinical Screening Platform for Pain” Program - StockTitan

Nov 05, 2024
pulisher
Oct 16, 2024

Artelo Biosciences (ARTL) Stock Surges Amid Bullish Analyst Rati - GuruFocus.com

Oct 16, 2024
pulisher
Oct 09, 2024

Artelo Biosciences CEO to Participate in Fireside Chat at the Maxim Group Virtual Healthcare Summit on October 16th - The Manila Times

Oct 09, 2024
pulisher
Oct 05, 2024

How doctors hope new cannabis drug will help cancer patients gain weight - inews

Oct 05, 2024
pulisher
Oct 02, 2024

FABP5 inhibitor ART-26.12 exhibits activity in psoriasis models - BioWorld Online

Oct 02, 2024
pulisher
Oct 01, 2024

Artelo Biosciences shares initiated with Buy by EF Hutton - Investing.com UK

Oct 01, 2024
pulisher
Oct 01, 2024

EF Hutton Initiates Coverage of Artelo Biosciences (ARTL) with Buy Recommendation - MSN

Oct 01, 2024
pulisher
Sep 27, 2024

Equities Analysts Offer Predictions for Stitch Fix, Inc.’s Q1 2025 Earnings (NASDAQ:SFIX) - Defense World

Sep 27, 2024
pulisher
Sep 27, 2024

Artelo Biosciences, Inc. (NASDAQ:ARTL) Short Interest Update - Defense World

Sep 27, 2024
pulisher
Sep 19, 2024

Anorexia Nervosa Market Expected to Experience Major Growth - openPR

Sep 19, 2024
pulisher
Sep 10, 2024

ARTL stock touches 52-week low at $1.12 amid market challenges - Investing.com Canada

Sep 10, 2024
pulisher
Sep 04, 2024

Artelo Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference - ForexTV.com

Sep 04, 2024
pulisher
Aug 21, 2024

ARTL Stock Earnings: Artelo Biosciences Beats EPS for Q2 2024 - MSN

Aug 21, 2024
pulisher
Aug 18, 2024

ARTLW (Artelo Biosciences) EV-to-Revenue : (As of Aug. 18, 2024) - GuruFocus.com

Aug 18, 2024
pulisher
Aug 18, 2024

ARTL (Artelo Biosciences) EV-to-Revenue : (As of Aug. 18, 2024) - GuruFocus.com

Aug 18, 2024
pulisher
Aug 17, 2024

ARTL (Artelo Biosciences) EV-to-Revenue : (As of Aug. 17, 2024) - GuruFocus.com

Aug 17, 2024
pulisher
Aug 17, 2024

HC Wainwright Weighs in on Artelo Biosciences, Inc.’s Q3 2024 Earnings (NASDAQ:ARTL) - Defense World

Aug 17, 2024
pulisher
Aug 15, 2024

Artelo Biosciences’ (ARTL) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Aug 15, 2024
pulisher
Aug 15, 2024

Artelo Biosciences (NASDAQ:ARTL) Announces Earnings Results - Defense World

Aug 15, 2024
pulisher
Aug 13, 2024

Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update - BioSpace

Aug 13, 2024
pulisher
Aug 13, 2024

Artelo Biosciences, Inc. (NASDAQ:ARTL) Short Interest Up 3,808.3% in July - Defense World

Aug 13, 2024
pulisher
Jul 26, 2024

Artelo Biosciences, Inc. (NASDAQ:ARTL) Short Interest Down 91.5% in July - Defense World

Jul 26, 2024
pulisher
Jul 20, 2024

New drug to control pain related to cancer treatment originally developed at Stony Brook gets FDA clearance - TBR News Media

Jul 20, 2024
pulisher
Jul 19, 2024

UK life sciences can lead the way in global cannabinoid R&D says CRDG report - European Pharmaceutical Manufacturer

Jul 19, 2024
pulisher
Jul 16, 2024

Artelo’s FABP5 inhibitor cleared to enter clinic for chemotherapy-induced peripheral neuropathy - BioWorld Online

Jul 16, 2024
pulisher
Jul 16, 2024

Artelo Biosciences Inc (ARTL)’s Market Momentum: Closing Strong at 1.33, Up 2.71 - The Dwinnex

Jul 16, 2024
pulisher
Jul 15, 2024

FDA greenlights Artelo Biosciences' neuropathy drug trial By Investing.com - Investing.com Nigeria

Jul 15, 2024
pulisher
Jul 15, 2024

PSEG sets $0.60 quarterly dividend for Q3 2024 By Investing.com - Investing.com

Jul 15, 2024
pulisher
Jul 15, 2024

Artelo Biosciences Inc (ARTL) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle

Jul 15, 2024
pulisher
Jul 15, 2024

FDA clears Artelo’s FABP5 inhibitor trial - Yahoo Finance

Jul 15, 2024
pulisher
Jul 15, 2024

Artelo stock jumps 13% after FDA okays ART26.12 Phase 1 study (NASDAQ:ARTL) - Seeking Alpha

Jul 15, 2024
pulisher
Jul 15, 2024

Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor - ForexTV.com

Jul 15, 2024
pulisher
Jul 05, 2024

Pharmacokinetic evaluation of novel cannabidiol formulation presented - BioWorld Online

Jul 05, 2024
pulisher
Jul 03, 2024

Artelo Biosciences Presents Data From Preclinical Studies On ART12.11 At 34th Annual International Cannabinoid Research Society Symposium - Quantisnow

Jul 03, 2024
pulisher
Jul 03, 2024

Artelo Biosciences Presents Comparative Data from Key Preclinical Studies on ART12.11 at the 34th Annual International Cannabinoid Research Society Symposium - Yahoo Finance

Jul 03, 2024
pulisher
Jul 02, 2024

Artelo Biosciences Announces Data Supporting Broad Potential Utility of its FABP Inhibitor Platform - StockTitan

Jul 02, 2024
pulisher
Jul 01, 2024

Artelo Biosciences Presents Preclinical Data on ART26.12 in Breast Cancer-Induced Bone Pain at the 34th Annual International Cannabinoid Research Society Symposium - Quantisnow

Jul 01, 2024
pulisher
Jun 29, 2024

Q4 Investor Summit Small Cap & Micro Cap Conference To Offer Opportunity to Meet with C-level Management of 90 ... - The Globe and Mail

Jun 29, 2024
pulisher
Jun 27, 2024

Artelo Biosciences Appoints Finance and Healthcare Industry Executive Tamara A. Seymour to Board of Directors - Quantisnow

Jun 27, 2024
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
자본화:     |  볼륨(24시간):